Post-Transplant Low-Dose Azacitidine Can Improve Overall Survival in AML/MDS Patients and is Associated with Decrease Risks of Severe Acute and Chronic Gvhd Meeting Abstract

cited authors

  • Mori, Shahram; Patel, Rushang D.; Balls, Jason Willard; Smith, Megan; Yuan, Cai; Nelson, Megan Marie; Zhang, Xiang; Goldstein, Steven C.

authors

Publication Date

  • March 1, 2018

webpage

published in

category

start page

  • S327

end page

  • S327

volume

  • 24

issue

  • 3